Galapagos

Galapagos Touts Positive Post-Hoc Data, but Likely Won’t Gun for US Approval
BioSpace
Mon, 07/12/21 - 11:35 pm
Galapagos
ulcerative colitis
filgotinib
Galapagos reports long-awaited safety data for inflammation drug
BioPharma Dive
Thu, 03/4/21 - 11:26 pm
Galapagos
inflammation
clinical trials
filgotinib
Gilead's $5B Galapagos black hole widens as pair toss out phase 3 asset after flop
Fierce Biotech
Wed, 02/10/21 - 10:29 am
Gilead Sciences
Galapagos
IPF
ziritaxestat
Gilead downsizes multibillion-dollar deal once at center of CEO's rebuild
Bizjournals
Tue, 12/15/20 - 08:31 pm
Gilead Sciences
Galapagos
clinical trials
filgotinib
rheumatoid arthritis
inflammatory bowel disease
Galapagos “win” highlights crowded idiopathic pulmonary fibrosis pipeline
EP Vantage
Fri, 12/4/20 - 10:48 am
Galapagos
GLPG1205
idiopathic pulmonary fibrosis
clinical trials
Galapagos' osteoarthritis drug flunks phase 2, dashing hopes of $250M Gilead deal
Fierce Biotech
Fri, 10/16/20 - 11:11 am
Galapagos
Servier
GLPG1972
osteoarthritis of the knee
clinical trials
Gilead and Galapagos's filgotinib shows sustained efficacy in ulcerative colitis study
Seeking Alpha
Tue, 10/13/20 - 11:17 am
filgotinib
Gilead Sciences
Galapagos
clinical trials
ulcerative colitis
Go or no go? Valuable drugs set for FDA decisions
EP Vantage
Wed, 07/29/20 - 10:54 am
FDA
drug approvals
Novartis
inclisiran
Biomarin
valrox
Roche
risdiplam
GSK
belantamab mafodotin
Gilead Sciences
Galapagos
filgotinib
3 Biotech Stocks With Big Incoming Catalysts
Motley Fool
Sat, 07/25/20 - 02:25 pm
FDA
GW Pharma
Epidiolex
filgotinib
Galapagos
Biomarin
valoctocogene roxaparvovec
Go or no go? Pandemic looms over FDA timelines
EP Vantage
Wed, 07/1/20 - 10:54 am
Jazz Pharma
Gilead Sciences
Galapagos
GSK
FDA
pandemic
COVID-19
Gilead builds case for filgotinib in active psoriatic arthritis
Fierce Biotech
Mon, 06/8/20 - 10:38 am
Gilead Sciences
Galapagos
filgotinib
clinical trials
psoriatic arthritis
Gilead shows durability of filgotinib ahead of face-off with AbbVie
Fierce Biotech
Thu, 06/4/20 - 11:00 am
Gilead Sciences
Galapagos
clinical trials
filgotinib
rheumatoid arthritis
Galapagos finds little comfort in safety
EP Vantage
Fri, 05/22/20 - 10:28 am
Galapagos
filgotinib
ulcerative colitis
Gilead's filgotinib phase 3 hits primary endpoint but details dampen hopes
Fierce Biotech
Thu, 05/21/20 - 10:28 am
Gilead Sciences
Galapagos
filgotinib
ulcerative colitis
clinical trials
Big pharma heads towards important readouts
EP Vantage
Wed, 05/20/20 - 10:22 am
Ozempic
Novo Nordisk
etrolizumab
Roche
Ipatasertib
finerenone
Bayer
filgotinib
Gilead Sciences
Galapagos
Avalglucosidase alfa
Sanofi
Rinvoq
AbbVie
clinical trials
Galapagos CEO talks next steps as coronavirus stalls the biotech's top drug
BioPharma Dive
Wed, 03/25/20 - 11:41 pm
Galapagos
Gilead Sciences
filgotinib
rheumatoid arthritis
FDA
COVID-19
Lilly, Galapagos halt trials as coronavirus deepens impact on drug research
BioPharma Dive
Mon, 03/23/20 - 12:00 pm
Eli Lilly
Galapagos
ObsEva
clinical trials
COVID-19
Gilead/Galapagos, Intercept and Corbus trials could be hit by coronavirus spread: analyst
Fierce Biotech
Wed, 03/11/20 - 10:55 am
clinical trials
Gilead Sciences
Galapagos
Corbus Pharmaceuticals
Intercept Pharmaceuticals
coronaviruses
COVID-19
Upcoming events – Filgotinib's ulcerative colitis data and serlopitant takes on pruritus
EP Vantage
Fri, 02/21/20 - 10:35 am
Gilead Sciences
Galapagos
filgotinib
ulcerative colitis
Menlo Therapeutics
serlopitant
Galapagos bags option on 4 more Fibrocor programs
Fierce Pharma
Wed, 01/15/20 - 10:54 am
Galapagos
fibrosis
Fibrocor

Pages